The International Classification of Diseases (ICD) by the World Health Organization (WHO) has been in use since 1900. Since it is only slightly more than a year since the October 2015 launch of ICD-10 in the United States, any discussion of ICD-11 may seem premature. It should be noted that ICD-10 was first published in 1990 and was originally scheduled to begin to be used in the U.S. in 2008, so an updated ICD is due after 27 years.
As allergists/immunologists, we are aware that the coding nomenclature for many of the diseases we treat does not always fit into how we look at these diseases and seems outdated. For this reason, a work group was established consisting of allergists/immunologists from all of the major global allergy societies (ACAAI, AAAAI, EAACI, WAO) to contribute to and influence the WHO’s decisions on ICD nomenclature for allergic diseases. James Sublett, MD, FACAAI, executive director of advocacy and governmental affairs, has been involved in several prior publications related to this project.
In this month’s issue of the Annals of Allergy, Asthma, & Immunology, Dr. Sublett, along with Advocacy Council Chair, Allen Meadows, MD, FACAAI, and the longtime Advocacy Council coding expert, Gary Gross, MD, FACAAI, are coauthors of an article Perspectives on the International Classification of Diseases, 11th Revision, developments in allergy clinical practice in the United States . It may be several years before we see ICD-11, but rest assured that the allergy community, including your Advocacy Council leadership, is providing much needed input.